Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (371-380 of 532) with videos related to

Pageof 54
Sort By:
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switchingMasaki Kashiwada, Deborah M Levy, Lisa McKeag, et al.
Synapse (New York, N.Y.)|September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrainRichard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
Synapse (New York, N.Y.)|November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.
European Journal of Medicinal Chemistry|February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activityMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Neurochemical Research|September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Pageof 54

Showing results (371-380 of 532) with videos related to

Sort By:
Pageof 54
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switchingMasaki Kashiwada, Deborah M Levy, Lisa McKeag, et al.
Synapse (New York, N.Y.)|September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrainRichard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
Synapse (New York, N.Y.)|November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.
European Journal of Medicinal Chemistry|February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activityMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Neurochemical Research|September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Pageof 54